FDA approves ‘follow-up’ pill

Getty Images

Us regulators have approved the first pill that can be digitally tracked through the body.

The Abilify MyCite aripiprazole tablets – for the treatment of schizophrenia and manic episodes – an ingestible sensor embedded within them that the records that the medication has been taken.

A patch worn by the patient transmits this information to your smart phone.

The information can also be sent to the prescribing physician, if the patient gives their consent to the.

Experts in the hope that it might improve medication compliance, although the company that makes the pills says that this has not been tested for your product.

The prescription is observed, in addition, the stress that Abilify MyCite should not be used for the monitoring of the ingestion of drugs in “real-time” or during an emergency, due to the detection may be delayed or may not occur. The stomach of liquid

The tablets are not licensed to be used in elderly patients with dementia-related psychosis.

About the size of a grain of sand, the sensor is activated when it comes into contact with stomach fluid.

It can take from 30 minutes to two hours to detect ingestion of the pill.

Mitchell Mathis, of the Food and Drug Administration, said: “to Be able to keep track of the ingestion of prescription drugs for mental illness can be helpful for some patients.

“The FDA supports the development and use of new technologies in the prescription drugs and is committed to working with businesses to understand how technology can benefit both patients and prescribers.”